Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

Emma E. Craythorne^*, Ghulam Mufti, Anthony W. duVivier

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	1064-1065
Number of pages	2
Journal	Journal of the American Academy of Dermatology
Volume	65
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2010.06.033
Publication status	Published - Nov 2011

Access to Document

@article{555ed5a75aea4df9ace9105839dd865b,

title = "Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris",

author = "Craythorne, {Emma E.} and Ghulam Mufti and duVivier, {Anthony W.}",

year = "2011",

month = nov,

doi = "10.1016/j.jaad.2010.06.033",

language = "English",

volume = "65",

pages = "1064--1065",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris

AU - Craythorne, Emma E.

AU - Mufti, Ghulam

AU - duVivier, Anthony W.

PY - 2011/11

Y1 - 2011/11

U2 - 10.1016/j.jaad.2010.06.033

DO - 10.1016/j.jaad.2010.06.033

M3 - Letter

SN - 0190-9622

VL - 65

SP - 1064

EP - 1065

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -